SCHEMBL4125539

CC(=O)NC1C(O)[C@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O[C@]3(OC=O)C[C@@H](O)[C@@H](C)C([C@H](O)[C@H](O)CO)O3)C2O)[C@H](CO)O[C@H]1OC1[C@@H](OCC2O[C@@H](O[C@@H]3C(CO)O[C@@H](O[C@@H]4C(CO)O[C@@H](C)C(NC(C)=O)[C@H]4O)C(NC(C)=O)[C@H]3O)C(O)[C@@H](O[C@H]3OC(CO)[C@@H](O)C(O)C3O[C@@H]3OC(CO)[C@@H](O[C@@H]4OC(CO[C@]5(OC=O)C[C@@H](O)[C@@H](C)C([C@H](O)[C@H](O)CO)O5)[C@H](O)[C@H](O)C4O)[C@H](O)C3NC(C)=O)[C@@H]2O)OC(CO)[C@@H](O)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	SELE	P16581	4/20	0.47

▸	SIGLEC7	Q9Y286	6/20	0.47

▸	MAG	P20916	7/20	0.47

▸	SELL	P14151	2/20	0.41

▸	SELP	P16109	1/20	0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL12197080	1.00	SELE (0.47)	SELESIGLEC7MAGSELLSELP
SCHEMBL17195870	1.00	SELE (0.47)	SELESIGLEC7MAGSELLSELP
SCHEMBL16232782	1.00	SELE (0.47)	SELESIGLEC7MAGSELLSELP
SCHEMBL16232781	1.00	SELE (0.47)	SELESIGLEC7MAGSELLSELP
SCHEMBL17195867	1.00	SELE (0.47)	SELESIGLEC7MAGSELLSELP
SCHEMBL16312021	1.00	SELE (0.47)	SELESIGLEC7MAGSELLSELP
SCHEMBL16232771	1.00	SELE (0.47)	SELESIGLEC7MAGSELLSELP
SCHEMBL4118092	1.00	SELE (0.47)	SELESIGLEC7MAGSELLSELP
SCHEMBL12197065	0.98	SELE (0.48)	SELESIGLEC7MAGSELLSELP
SCHEMBL15849099	0.98	SELE (0.48)	SELESIGLEC7MAGSELLSELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-9937264-B2	Glycosylated polypeptide and drug composition containing said polypeptide	GLYTECH, INC. (JP)	2018-04-10	—	—	US	disclosed
US-9802996-B2	Glycosylated polypeptide and drug composition containing said polypeptide	GLYTECH, INC. (JP)	2017-10-31	—	—	US	disclosed
US-20170157260-A1	Glycosylated Polypeptide and Drug Composition Containing said Polypeptide	GLYTECH, INC. (JP)	2017-06-08	—	—	US	disclosed
US-20160368961-A1	Glycosylated Polypeptide and Drug Composition Containing said Polypeptide	GLYTECH, INC. (JP)	2016-12-22	—	—	US	disclosed
US-9441024-B2	Glycosylated polypeptide and drug composition containing said polypeptide	GLYTECH, INC. (JP)	2016-09-13	—	—	US	disclosed
US-20140315800-A1	Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide	GLYTECH, INC. (JP)	2014-10-23	—	—	US	disclosed
US-8765669-B2	Glycosylated GLP-1 peptide	GLYTECH, INC. (JP)	2014-07-01	—	—	US	disclosed
US-20120114595-A1	SUGAR CHAIN-ADDED AILIM EXTRACELLULAR DOMAIN AND METHOD FOR PRODUCING SAME	OTSUKA CHEMICAL CO., LTD. (JP)	2012-05-10	—	—	US	disclosed
US-20110195897-A1	GLYCOSYLATED GLP-1 PEPTIDE	OTSUKA CHEMICAL CO., LTD. (JP)	2011-08-11	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20110195897-A1	GLYCOSYLATED GLP-1 PEPTIDE	GLP1R, GIPR, IAPP	SELE 200/4885SIGLEC7 102/4885MAG 1399/4885
US-20170157260-A1	Glycosylated Polypeptide and Drug Composition Containing said Polypeptide	GIPR, SSTR4, SSTR3	SELE 428/4885SIGLEC7 100/4885MAG 784/4885
US-20120114595-A1	SUGAR CHAIN-ADDED AILIM EXTRACELLULAR DOMAIN AND METHOD FOR PRODUCING SAME	SIGLEC7, ENGASE, SIGLEC9	SELE 50/4885SIGLEC7 1/4885MAG 319/4885
US-20160368961-A1	Glycosylated Polypeptide and Drug Composition Containing said Polypeptide	GIPR, SSTR3, SSTR4	SELE 440/4885SIGLEC7 92/4885MAG 766/4885
US-20140315800-A1	Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide	GIPR, SSTR3, SSTR4	SELE 440/4885SIGLEC7 92/4885MAG 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.